Roy Vagelos net worth is $479 Million. Let’s delve into the intricacies of his financial empire and explore the factors contributing to his wealth.
Roy Vagelos Net Worth
P Roy Vagelos’s Holdings:
1. Directorship at Regeneron Pharmaceuticals Inc:
As the Director of Regeneron Pharmaceuticals Inc, P Roy Vagelos owns an impressive 501,738 shares of REGN stock, valued at over $479 Million. This substantial holding forms the cornerstone of his financial portfolio.
Also Read: Kelly Ripa Net Worth
Insider Information and Transactions:
Unveiling the Numbers
2. SEC Filings and Net Worth Estimation
The insider information we possess is derived from SEC filings, forming the basis of P Roy Vagelos’s estimated net worth. This estimation assumes no transactions post-March 30, 2022, indicating a sustained holding strategy.
Also Read: Vivica Fox Net Worth
3. Transaction Summary
Despite the lack of recent data, we unveil a historical overview. P Roy Vagelos has executed 7 transactions in Regeneron Pharmaceuticals Inc over the past 5 years, showcasing a strategic blend of buys and sells. Notably, the most recent sale on March 30, 2022, brought in approximately $20 Million.
Also Read: Daniel Neeleman Net Worth
Insider Ownership Landscape:
A Comprehensive Analysis
4. Ownership Reports and Network Relations P Roy Vagelos’s ownership extends to 2 companies:
Regeneron Pharmaceuticals Inc and Innoviva Inc. A closer look at ownership reports from SEC filings offers a detailed understanding of his stakes in these entities.
Also Read: Who is Big Jook
5. Insider Trading History
Dive into the intricate details of P Roy Vagelos’s insider trading history. Over the past 18 months, his involvement in Regeneron Pharmaceuticals Inc remained significant, with 40,700 shares net sold.
P Roy Vagelos’s Impact on Regeneron Pharmaceuticals Inc
Also Read: Adam Copeland Net Worth
6. Key Executives and Company Details
Explore the leadership landscape at Regeneron Pharmaceuticals Inc, with P Roy Vagelos playing a pivotal role as the Director. Uncover key executives, including SVP Commercial Marion Mccourt, President and CSO George Yancopoulos, and VP & Controller Christopher R. Fenimore.
Also Read: Hank Baskett Net Worth
7. Insider Transactions Beyond P Roy Vagelos
In the broader context, other recent insider transactions involving Regeneron Pharmaceuticals Inc are highlighted, providing a holistic view of the company’s internal dynamics.
Analyzing Insider Trading Patterns: Beyond the Numbers
Also Read: Nexersys Net Worth
8. Insider Trading Tracker
Gain insights into the comprehensive insider trading history of Regeneron Pharmaceuticals Inc. Understand the patterns, trends, and the broader impact on the company’s stock.
Also Read: Michele Lamy Net Worth
9. Ownership Network Relation
Explore the ownership network relation of P Roy Vagelos, shedding light on the intricate connections within the corporate landscape.
P Roy Vagelos:
Also Read: Big Jook Net Worth
10. Professional Background and Contributions
Uncover P Roy Vagelos’s significant contributions beyond his financial endeavors. His role as a director and the impact on the pharmaceutical industry merits attention.